P
Pharma
387 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
195
Activity (Last 30 Days)
2
4
4
3
3
1
4
4
6
6
2
1
2
4
2
6
2
2
4
2
3
1
2026-03-232026-04-19
Top Publishers
Stat News187 stories
Google News3 stories
Financial Times1 stories
CNBC1 stories
South China Morning Post1 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: Replimune skin cancer drug that became FDA flashpoint is rejected again
Stat News|4/10/2026
UNVERIFIEDSingle Source
STAT+: Terns’ drug may not be as competitive as many initially thought
Stat News|4/8/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Trump’s drug tariffs, a U.S.-U.K. pharma trade deal, and more
Stat News|4/3/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: Psychedelic biotechs face scrutiny over YouTube promos
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: Gilead to acquire immunology biotech, offers lifeline to Galapagos
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about a Trump drug pricing flaw, a Gilead deal, and more
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: The potential loophole in Trump’s plan to get other countries to pay more for drugs
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Iran war’s impact on pharma supply chain, a Pfizer Lyme vaccine, and more
Stat News|3/23/2026
UNVERIFIEDSingle Source
STAT+: U.K. to take another look at cost-effectiveness of Alzheimer’s drugs
Stat News|3/20/2026
UNVERIFIEDSingle Source
STAT+: Novartis picks up experimental breast cancer therapy for $2B
Stat News|3/20/2026
UNVERIFIEDSingle Source
STAT+: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: J&J wins approval for first-of-its-kind psoriasis pill
Stat News|3/18/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about obesity pill trial results, cholesterol guidelines, and more
Stat News|3/16/2026
UNVERIFIEDSingle Source
Analysis of Medicare data shows who mental health providers treat over telehealth
Stat News|3/12/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about the FDA warning Novo Nordisk, Lilly investing in China, and more
Stat News|3/11/2026
UNVERIFIEDSingle Source
Stocks making the biggest moves midday: Chevron, Hims and Hers, Xenon Pharma, Vertiv and more
CNBC|3/9/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales
Stat News|3/9/2026
UNVERIFIEDSingle Source
STAT+: Pharmalot: We’re reading about a lack of FDA adcomms, FDA loosening biosimilar rules, and more
Stat News|3/9/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about an FDA-UniQure tussle, a Pfizer obesity drug approval in China, and more
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: FDA warns more telehealth firms about compounded GLP-1s
Stat News|3/4/2026
UNVERIFIEDSingle Source
STAT+: Prime Medicine to seek approval for gene editing treatment after two-patient trial
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about an FDA-UniQure feud, Pfizer’s ‘problem’ with the agency, and more
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Trump’s MFN deals, 340B program controversies, and much more
Stat News|3/2/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about FDA and a ‘smear campaign,’ Cigna buying a large pharmacy, and more
Stat News|2/27/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugs
Stat News|2/25/2026
UNVERIFIEDSingle Source
STAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experiments
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about an FDA official’s speech, a Grail cancer blood test, and much more
Stat News|2/20/2026
UNVERIFIEDSingle Source
STAT+: In first speech to her FDA staff, Høeg says she’ll scrutinize RSV shots and SSRIs in pregnancy
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: At drugmakers’ forum, Oz gets a friendly embrace, while Makary faces tough questions
Stat News|2/17/2026
UNVERIFIEDSingle Source
STAT+: FDA’s rejection of Moderna threatens to stifle broader vaccine industry
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: White House looks for more drug pricing deals to add to TrumpRx
Stat News|2/6/2026
UNVERIFIEDSingle Source
Statins don’t cause most of the side effects on package warnings, study finds
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Pfizer moves forward with its hopes for a monthly obesity drug
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about pharma lobbying, an FDA gene-editing pathway, and more
Stat News|1/26/2026
UNVERIFIEDSingle Source
“I am very annoyed”: Pharma execs blast RFK Jr.’s attack on vaccines - Ars Technica
Google News|1/15/2026
UNVERIFIEDSingle Source
FDA tells Sanofi, GSK, AZ and CSL to include warnings for febrile seizures on flu shot labels - Fierce Pharma
Google News|1/15/2026